$16.23 +0.54 (%) Regulus Therapeutic Inc - NASDAQ

Nov. 21, 2014 | 04:00 PM

Partner Headlines

  1. Morning Market Losers

    Benzinga | Nov. 13, 2014 | 09:49AM EST
  2. Benzinga's Top #PreMarket Losers

    Benzinga | Nov. 13, 2014 | 08:16AM EST
  3. Stocks Hitting 52-Week Highs

    Benzinga | Nov. 10, 2014 | 10:17AM EST
  4. Benzinga's Volume Movers

    Benzinga | Oct. 29, 2014 | 11:23AM EST
  5. Morning Market Movers

    Benzinga | Oct. 29, 2014 | 09:46AM EST
  6. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 29, 2014 | 08:12AM EST
  7. A Quick Primer On Regulus Therapeutics And Its Upside Potential

    Benzinga | Oct. 28, 2014 | 11:19AM EST
  8. Midday Gainers From October 27: Micron Technology, Regulus Therapeutics, CyberArk Software And More

    Benzinga | Oct. 27, 2014 | 13:24PM EST
  9. Morning Market Losers

    Benzinga | Oct. 27, 2014 | 10:07AM EST
  10. Benzinga's Top #PreMarket Losers

    Benzinga | Oct. 27, 2014 | 08:21AM EST
  11. 3D Systems Slips On Profit Warning; Regulus Therapeutics Shares Spike Higher

    Benzinga | Oct. 22, 2014 | 15:29PM EST
  12. U.S. Stocks Fall; iRobot Shares Gain On Upbeat Results

    Benzinga | Oct. 22, 2014 | 14:17PM EST
  13. Markets Mostly Flat; Boeing Raises Earnings Forecast

    Benzinga | Oct. 22, 2014 | 10:42AM EST
  14. Regulus Therapeutics Soars 90% On Hepatitis C Treatment News

    Benzinga | Oct. 22, 2014 | 10:39AM EST
  15. Benzinga's Volume Movers

    Benzinga | Oct. 22, 2014 | 10:25AM EST
  16. Stocks Hitting 52-Week Highs

    Benzinga | Oct. 22, 2014 | 10:17AM EST
  17. Morning Market Movers

    Benzinga | Oct. 22, 2014 | 09:42AM EST
  18. Regulus Therapeutics Says Glaxo Group Terminated 2008 Pact

    Benzinga | Oct. 22, 2014 | 08:52AM EST
  19. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 22, 2014 | 08:34AM EST
  20. Wedbush Securities Reacts To Regulus Therapeutics Inc Announcing ATHENA Natural History Study

    Benzinga | Sep. 19, 2014 | 07:52AM EST
  21. S&P 500 Marks New High As Indexes Hold Gains

    IBD | Aug. 21, 2014 | 16:30PM EST
  22. Regulus Renews Strategic Alliance with Sanofi to Focus on Orphan Disease and Oncology Targets and Receives Additional $10M Equity Investment

    Benzinga | Feb. 5, 2014 | 08:06AM EST
  23. UPDATE: BMO Capital Markets Raises PT on Regulus Therapeutics Following 2Q13 Operating Results

    Benzinga | Aug. 14, 2013 | 11:18AM EST
  24. Stocks Hitting 52-Week Highs

    Benzinga | Dec. 28, 2012 | 04:14AM EST
  25. UPDATE: Wedbush Securities Initiates Regulus Therapeutics at Outperform on Pipeline Progress

    Benzinga | Nov. 29, 2012 | 06:35AM EST
  26. Regulus Appoints Douglas Williams, Ph.D. to its Board of Directors

    Benzinga | Nov. 7, 2012 | 01:05AM EST
Trading Center